WIPO Re:Search Database

The WIPO Re:Search Database is composed of intellectual property assets, including compounds, enabling technologies, know-how, and other information that Providers have chosen to make available in WIPO Re:Search. All the information is publicly available and can be accessed without registration.

Please watch this space as Providers regularly upload additional entries and new Providers join WIPO Re:Search.

To inquire further about any particular items in the database, please note the Submission ID and submit a request or contact the Partnership Hub.

Alnylam
AstraZeneca (AZ)
Caltech
Center for World Health and Medicine (CWHM)
Drugs for Neglected Diseases initiative (DNDi)
Eisai
Eskitis Institute
GlaxoSmithKline (GSK)
Massachussets Institute of Technology (MIT)
McGill University (McGill)
Medicines for Malaria Venture (MMV)
Merck (MSD)
NIH (USA)
Northeastern University (NEU)
Novartis
PATH
Pfizer
Sanofi
University of California Berkeley
University of Kansas (KU)
Walter Reed Army Institute of Research (WRAIR)
 
 
 
 

 

Disclaimer

Any access, browsing and/or use of the WIPO Re:Search Database is governed by the Terms of use. In accepting the Terms of use for access to this database, it is thereby also acknowledged that the Intellectual Property detailed in the database is offered for possible license only pursuant to an individually negotiated license under terms to be agreed with the indicated owner of that Intellectual Property and no implied license under listed Intellectual Property is derived from access to this database.

WIPO Re:Search

Technical Advisor to WIPO